BIB icon

ProShares Ultra NASDAQ Biotechnology
BIB

Overview Fund Activity

27 hedge funds and large institutions have $42.7M invested in ProShares Ultra NASDAQ Biotechnology in 2015 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 13 increasing their positions, 6 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
27
Holders Change
+3
Holders Change %
+12.5%
% of All Funds
0.71%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
6
Increased
13
Reduced
6
Closed
3
Calls
$32.8M
Puts
$22.9M
Net Calls
+$9.95M
Net Calls Change
+$36.2M

Top Buyers

1
VF
1
Virtu Financial
New York
$8.24M
2
Susquehanna International Group
2
Susquehanna International Group
Pennsylvania
$2.95M
3
Jane Street
3
Jane Street
New York
$1.99M
4
TRCT
4
Tower Research Capital (TRC)
New York
$1.9M
5
LPL Financial
5
LPL Financial
California
$2.51M

Top Sellers

1
OPPM
1
Opus Point Partners Management
New York
$1.07M
2
VCAM
2
Valentine Capital Asset Management
California
$3.58M
3
WSTAM
3
Wilbanks Smith & Thomas Asset Management
Virginia
$0
4
Bank of America
4
Bank of America
North Carolina
$206K
5
TCM
5
Traynor Capital Management
Pennsylvania
$405K
Name Holding Trade Value Shares
Change 		Shares
Change %
Royal Bank of Canada
26
Royal Bank of Canada
Ontario, Canada
$13K +$7.94K +110 +157%
MFS
27
MSI Financial Services
Massachusetts
$7K +$7K +100 New
WSTAM
28
Wilbanks Smith & Thomas Asset Management
Virginia
– -$474K -8,140 Closed
GT
29
Glenmede Trust
Pennsylvania
– -$13K -230 Closed
BCI
30
Brinker Capital Investments
Pennsylvania
– -$1K -20 Closed
1
2